期刊文献+

不同钙离子浓度透析液在腹膜透析患者中的应用 被引量:3

原文传递
导出
摘要 矿物质和骨代谢紊乱(MBD)是慢性肾脏病(CKD),特别是终末期肾脏病(ESRD)透析患者的常见并发症,可以导致血管钙化和心血管事件发生的危险性增加,
作者 赵慧萍 王梅
出处 《中华肾脏病杂志》 CAS CSCD 北大核心 2011年第10期791-793,共3页 Chinese Journal of Nephrology
  • 相关文献

参考文献26

  • 1Raggi P, Boulay A, Chasan-Taber S, et al. Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease? J Am Coll Cardiol, 2002, 20, 39: 695-701.
  • 2Goodman WG, Goldin J, Kuizon BD, et al. Coronary-arteey calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med, 2000, 342: 1478-1483.
  • 3Block GA, Port FK. Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: recommendations for a change in management. Am J Kidney Dis, 2000, 35: 1226-1237.
  • 4Moe S, Druekc T, Cunningham J, et al. Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Iut, 2006, 69: 1945-1953.
  • 5Noordzij M, Korevaar JC, Bos W J, et al. Mineral metabolism and cardiovascular morbidity and mortality risk: peritoneal dialysis patients compared with hacmodialysis patients. Nephrol Dial Transplant, 2006, 21: 2513-2520.
  • 6Bro S, Brandi L, Daugaard H, et al. Calcium concentration in the CAPD dialysate: what is optimal and is there a need to individualize? Perit Dial Int, 1997, 17: 554-559.
  • 7Braun J, Oldendorf M, Moshage W, et al. Electron beam computed tomography in the evaluation of cardiac calcification in chronic dialysis patients. Am J Kidney Dis, 1996, 27: 394-401.
  • 8Yang H, Curinga G, Giachelli CM. Elevated extracellular calcium levels induce smooth muscle cell matrix mineralization in vitro. Kidney Int, 2004, 66: 2293-2299.
  • 9Block GA, Klassen PS, Lazarus JM, et al. Mineral metabolism, mortality, and morbidity in maintenance haemodialysis. J Am Soc Nephrol, 2004, 15: 2208-2218.
  • 10Tentori F, Blayney M, Albert JM, et al. Mortality risk for dialysis patients with different levels of serum calcium, phosphorus and PTH: the dialysis outcomes and practice patterns study (DOPPS). Am J Kidney Dis, 2008, 52: 519- 530.

二级参考文献11

  • 1De Vries JPPM, Kouw PM, van der Meer NJM. Non-invasive monitoring of blood volume during hemodialysis: Its relation with post-dialytic dry weight. Kidney Int, 1993, 44: 851.
  • 2Catherine C, Philippe M, Didier B. Lung, gastric, and soft tissue uptake of Tc-99m MDP and Ga-67 citrate associated with hypercalcemia. Clin Nucl Med, 2003, 28: 467-471.
  • 3Argilés A, Mourad G. How do we have to use the calcium in the dialysate to optimize the management of secondary hyperparathyroidism? Nephrol Dial Transplant, 1998, 13 Suppl 3:62-64.
  • 4Palmer, Biff F. Individualizing the dialysate in the hemodialysis patient. Semin Dial, 2001, 14: 41-49.
  • 5Hou SH, Zhao J, Ellman CF, et al. Calcium and phosphorus fluxes during hemodialysis with low calcium dialysate. Am J Kidney Dis,1991, 2: 217-224.
  • 6Argilés A, Kerr PG, Canaud B, et al. Hemodialysis and hemodiaffitration Ca kinetics, and the long-term effects of lowering dialysate calcium concentration. Kidney Int, 1993, 43: 630-640.
  • 7Yudd M, Liach F. Renal osteodystrophy. In: Brenner BM, ed.Dialysis and transplantation. 北京: 科学出版社, 2001.14:259-260.
  • 8Argilés A, Mion CM. Calcium balance and intact parathormone variations during haemodiafiltration. Nephrol Dial Transplant,1995, 10: 2083-2089.
  • 9Femández E, Borràs M, Pais B, et al. Low-calcium dialysate stimulates parathormone secretion and its long-term use worsens secondary hyperparathyroidism. J Am Soc Nephrol, 1995, 6:132-135.
  • 10Merwe WM, Rodger RS, Grant AG, et al. Low calcium dialysate and high oral calcitriol in the treatment of secondary hyperparathyroidism in haemodialysis patients. Nephrol Dial Transplant, 1990, 5: 874-877.

共引文献50

同被引文献21

引证文献3

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部